Since UBE2N activity correlates with increased protein expression of specific targets in AML, we hypothesized that UBE2N-mediated K63-linked ubiquitin chains prevent degradation of its targets by K48-linked ubiquitination and subsequent proteasomal degradation (Figure 5A). The gene discussed is UBE2N; the disease is acute myeloid leukemia.